These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32792075)

  • 1. Lipoprotein(a) and Family History Predict Cardiovascular Disease Risk.
    Mehta A; Virani SS; Ayers CR; Sun W; Hoogeveen RC; Rohatgi A; Berry JD; Joshi PH; Ballantyne CM; Khera A
    J Am Coll Cardiol; 2020 Aug; 76(7):781-793. PubMed ID: 32792075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk.
    Mehta A; Vasquez N; Ayers CR; Patel J; Hooda A; Khera A; Blumenthal RS; Shapiro MD; Rodriguez CJ; Tsai MY; Sperling LS; Virani SS; Blaha MJ; Joshi PH
    J Am Coll Cardiol; 2022 Mar; 79(8):757-768. PubMed ID: 35210030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Activity, Parental History of Premature Coronary Heart Disease, and Incident Atherosclerotic Cardiovascular Disease in the Atherosclerosis Risk in Communities (ARIC) Study.
    Florido R; Zhao D; Ndumele CE; Lutsey PL; McEvoy JW; Windham BG; Pankow JS; Guallar E; Michos ED
    J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome.
    Liu HH; Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Gao Y; Xu RX; Dong Q; Li JJ
    J Atheroscler Thromb; 2024 Sep; 31(9):1319-1332. PubMed ID: 38616111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
    Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
    J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    Wong ND; Fan W; Hu X; Ballantyne C; Hoodgeveen RC; Tsai MY; Browne A; Budoff MJ
    J Am Coll Cardiol; 2024 Apr; 83(16):1511-1525. PubMed ID: 38631771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a), family history of cardiovascular disease, and incidence of heart failure.
    Wang HP; Zhang N; Liu YJ; Xia TL; Chen GC; Yang J; Li FR
    J Lipid Res; 2023 Jul; 64(7):100398. PubMed ID: 37276941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Relationship of Lipoprotein(a) and Carotid Atherosclerosis With Long-Term Risk of Cardiovascular Disease.
    Qi Y; Duan Y; Deng Q; Yang N; Sun J; Li J; Hu P; Liu J; Liu J
    J Am Heart Assoc; 2024 May; 13(9):e033488. PubMed ID: 38639362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic Guanosine Monophosphate and Risk of Incident Heart Failure and Other Cardiovascular Events: the ARIC Study.
    Zhao D; Guallar E; Vaidya D; Ndumele CE; Ouyang P; Post WS; Lima JA; Ying W; Kass DA; Hoogeveen RC; Shah SJ; Subramanya V; Michos ED
    J Am Heart Assoc; 2020 Jan; 9(2):e013966. PubMed ID: 31928156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis.
    Guan W; Cao J; Steffen BT; Post WS; Stein JH; Tattersall MC; Kaufman JD; McConnell JP; Hoefner DM; Warnick R; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):996-1001. PubMed ID: 25810300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
    Small AM; Pournamdari A; Melloni GEM; Scirica BM; Bhatt DL; Raz I; Braunwald E; Giugliano RP; Sabatine MS; Peloso GM; Marston NA; Natarajan P
    JAMA Cardiol; 2024 Apr; 9(4):385-391. PubMed ID: 38353970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the Atherosclerosis Risk in Communities (ARIC) Study.
    Virani SS; Brautbar A; Davis BC; Nambi V; Hoogeveen RC; Sharrett AR; Coresh J; Mosley TH; Morrisett JD; Catellier DJ; Folsom AR; Boerwinkle E; Ballantyne CM
    Circulation; 2012 Jan; 125(2):241-9. PubMed ID: 22128224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.
    Patel AP; Wang (汪敏先) M; Pirruccello JP; Ellinor PT; Ng K; Kathiresan S; Khera AV
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):465-474. PubMed ID: 33115266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) as a cardiovascular risk factor: current status.
    Nordestgaard BG; Chapman MJ; Ray K; Borén J; Andreotti F; Watts GF; Ginsberg H; Amarenco P; Catapano A; Descamps OS; Fisher E; Kovanen PT; Kuivenhoven JA; Lesnik P; Masana L; Reiner Z; Taskinen MR; Tokgözoglu L; Tybjærg-Hansen A;
    Eur Heart J; 2010 Dec; 31(23):2844-53. PubMed ID: 20965889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.